Assignee
GENE SIGNAL INT SA
CH·9 granted patents·6 pending applications·16 citations·filing 2004–2018
Top patents by PatentIndex Score
15 records- 0186US7674770B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2007·Granted Mar 9, 2010·4 cites·19 claims
- 0284US9539306B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2014·Granted Jan 10, 2017·3 cites·9 claims
- 0380US7855184B2Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseasesGENE SIGNAL INT SA·Filed 2007·Granted Dec 21, 2010·4 cites·24 claims
- 0478US7993665B2Wound healing agent and compositionGENE SIGNAL INT SA·Filed 2008·Granted Aug 9, 2011·4 cites·9 claims
- 0572US10052343B1Sterile formulation comprising a stable phosphorothioate oligonucleotideGENE SIGNAL INT SA·Filed 2017·Granted Aug 21, 2018·1 cites·17 claims
- 0667US8372810B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2008·Granted Feb 12, 2013·0 cites·25 claims
- 0765US7906621B2Anti-tumor drug, medicament, composition, and use thereofGENE SIGNAL INT SA·Filed 2007·Granted Mar 15, 2011·0 cites·13 claims
- 0858US11357790B2Sterile formulation comprising a stable phosphorothioate oligonucleotideGENE SIGNAL INT SA·Filed 2018·Granted Jun 14, 2022·0 cites·14 claims
- 0954US7803906B2Composition comprising an angiogenesis related proteinGENE SIGNAL INT SA·Filed 2004·Granted Sep 28, 2010·0 cites·6 claims
- 1044US2008194478A1Wound healing agent and compositionGENE SIGNAL INT SA·Filed 2007·Application pending·0 cites
- 1142US2020172618A1Cd9p-1-targeting antibody and uses thereofGENE SIGNAL INT SA·Filed 2018·Application pending·0 cites
- 1240US2015283165A1Use of an inhibitor of irs-1 for treating skin disordersGENE SIGNAL INT SA·Filed 2013·Application pending·0 cites
- 1333US2013004511A1Composition comprising inhibitors of irs-1 and of vegfGENE SIGNAL INT SA·Filed 2011·Application pending·0 cites
- 1432US2017173106A1Polypeptide Fragments of 168A-T2 and Compositions Comprising Them for Use in Treating CancerGENE SIGNAL INT SA·Filed 2015·Application pending·0 cites
- 1531US2017035693A1Sterile Emulsion Comprising a Stable Phosphorothioate OligonucleotideGENE SIGNAL INT SA·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →